Fed. Circ. Ruling Won't Lead To Patents On DNA, Justices Told

By Britain Eakin (April 19, 2021, 7:54 PM EDT) -- Illumina urged the U.S. Supreme Court on Monday to reject a challenge by Ariosa and Roche to a split Federal Circuit ruling reviving its DNA-test patents after a district court invalidated them for claiming a natural phenomenon, contesting their argument that "serious ethical" issues are at stake.

Ariosa Diagnostics Inc. and Roche Sequencing Solutions claimed that the split Federal Circuit decision created a back door for patenting human DNA, but in response to their December petition for certiorari, Illumina argued that there is no reason for the high court to review the matter. Illumina initially waived the right to respond but was...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!